eChalk Talk: Bioanalytical Strategy for PK Assessments of ATMPs
The emergence of advanced therapeutic medicinal products (ATMPs), such as cell and gene therapies, has led to the increased utilization of specialized technology platforms in regulated bioanalysis.
Economical Preclinical PK Immunoassay
A start-up biotechnology company developed a library of constructs having the Fc portion of human IgG and their warhead denoted as X for confidential reasons. Fc-X fusion protein drug candidates were distinguished by amino acid substitutions in the warhead moiety, changes that were predicted to affect PK characteristics.
Safety and Efficacy Testing of Cell Therapies
An Overview of Cell Therapy: As we continue our blog series on cell and gene therapy, we will now dive into cell therapy programs. If…
Molecular Moments Podcast
[EPISODE 25] Adam Stasio Talks, Large Data Sets, Breaking Down Problems, and Tech-Driven Solutions
Science in 60 Videos
What is Luminex and How Does it Work?
Learn about how the Luminex platform works from one of our Boston Project Managers, Catarina Ferraz, and see how it allows for many analytes to…